First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gap
在低收入和中等收入国家,一线使用帕博利珠单抗治疗转移性非小细胞肺癌:弥合疗效与效果之间的差距
期刊:Immunotherapy
影响因子:2.3
doi:10.1080/1750743X.2025.2548754
Batra, Ullas; Sharma, Mansi; Miller, Alexis Andrew; Chufal, Kundan Singh; Ahmad, Irfan; Dewan, Abhinav; Chowdhary, Sabeena; Amrith, B P; Sachdeva, Rashi; Batra, Vanshika; Umesh, Preetha; Bhatia, Kratika; Nathany, Shrinidhi; Mehta, Anurag; Filho, Paulo Nunes; Tolba, Khaled; Chico, Isagani M; Boixader, Laura Vidal; Cantini, Luca; Saini, Kamal S